CTKB vs RF
Cytek Biosciences Inc (CTKB) versus RF (RF) — a side-by-side from cached financials, not a winner call.
Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.
RF (RF) common stock.
Latest reported CTKB revenue for 2024-12-31 was $200.5M. Net income was -$6.0M. Revenue was up 3.9% from 2023-12-31 to 2024-12-31. CTKB currently screens at market cap $421.8M.
RF does not have a complete income-statement cache yet.
CTKB currently screens at market cap $421.8M. RF currently screens at market cap $0.
Not investment advice. Open the CTKB and RF stock pages for the full models.
Not investment advice.